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Research
AbstrACt
Objectives While regular physical exercise has many 
health benefits, strenuous physical exercise may have a 
negative impact on cardiac function. The ‘Berlin Beat of 
Running’ study focused on feasibility and diagnostic value 
of continuous ECG monitoring in recreational endurance 
athletes during a marathon race. We hypothesised that 
cardiac arrhythmias and especially atrial fibrillation are 
frequently found in a cohort of recreational endurance 
athletes. The main secondary hypothesis was that 
pathological laboratory findings in these athletes are (in 
part) associated with cardiac arrhythmias.
Design Prospective observational cohort study including 
healthy volunteers.
setting and participants One hundred and nine 
experienced marathon runners wore a portable ECG 
recorder during a marathon race in Berlin, Germany. 
Athletes underwent blood tests 2–3 days prior, directly 
after and 1–2 days after the race.
results Overall, 108 athletes (median 48 years (IQR 
45–53), 24% women) completed the marathon in 
249±43 min. Blinded ECG analysis revealed abnormal 
findings during the marathon in 18 (16.8%) athletes. Ten 
(9.3%) athletes had at least one episode of non-sustained 
ventricular tachycardia, one of whom had atrial fibrillation; 
eight (7.5%) individuals showed transient ST-T-segment 
deviations. Abnormal ECG findings were associated with 
advanced age (OR 1.11 per year, 95% CI 1.01 to 1.23), 
while sex and cardiovascular risk profile had no impact. 
Directly after the race, high-sensitive troponin T was 
elevated in 18 (16.7%) athletes and associated with ST-T-
segment deviation (OR 9.9, 95% CI 1.9 to 51.5), while age, 
sex and cardiovascular risk profile had no impact.
Conclusions ECG monitoring during a marathon is 
feasible. Abnormal ECG findings were present in every 
sixth athlete. Exercise-induced transient ST-T-segment 
deviations were associated with elevated high-sensitive 
troponin T (hsTnT) values.
trial registration  ClinicalTrials. gov NCT01428778; 
Results.
IntrODuCtIOn
Regular physical exercise has many health 
benefits: improving blood pressure control, 
insulin sensitivity and lipid profiles; it reduces 
overall mortality and disability1 and the 
number of cardiovascular events.2 3 More-
over, regular physical exercise also reduces 
the risk of certain cancers4 and the number of 
mood disorders.5 However, highly strenuous 
physical exercise may have a negative impact 
on cardiovascular health.6 While marathon 
running has become a popular sport, cardiac 
arrest is rare but occurs in about 1:100 000 
marathon runners, most commonly in those 
with hypertrophic cardiomyopathy or athero-
sclerotic coronary disease.7 Available data 
strengths and limitations of this study
 ► This is so far the largest study demonstrating 
feasibility of non-invasive ECG recording during a 
marathon race.
 ► More than 100 experienced marathon runners 
underwent a unique serial blood sampling within 2–3 
days before the marathon, directly after crossing the 
finish line and 1–2 days after the marathon race.
 ► Cardiac MRI was performed in a subset of athletes 
with abnormal ECG findings and/or elevated troponin 
T values.
 ► Serial echocardiography and a standardised 
exercise capacity testing would have allowed for a 
more comprehensive interpretation of the results.
group.bmj.com on August 9, 2017 - Published by http://bmjopen.bmj.com/Downloaded from 
2 Herm J, et al. BMJ Open 2017;7:e015798. doi:10.1136/bmjopen-2016-015798
Open Access 
on incidence of myocardial infarction after running a 
marathon are limited to case reports8 and the prospective 
RACE Paris Registry,9 but elevated levels of troponin—a 
sensitive biomarker of cardiac injury—were reported in a 
relevant subset of asymptomatic marathon runners.10–12 
Other potentially harmful effects of strenuous exer-
cise, like right ventricular dysplasia and ventricular 
arrhythmia, have also been reported for triathletes 
and other ultra-endurance athletes.13–15 Moreover, a 
meta-analysis of mostly retrospective and small case–
control series as well as a recent cohort study indicated 
that intense endurance sport increases the long-term 
risk of atrial fibrillation (AF).16 17 The European Heart 
Rhythm Association (EHRA) consortium has recently 
updated its recommendations regarding abnormal 
ventricular arrhythmias in endurance athletes and stated 
that a non-sustained ventricular tachycardia (nsVT) 
requires diagnostic evaluation for latent hypertrophic 
cardiomyopathy or ischaemic heart disease, especially if 
these occur under physical exercise.18 However, there are 
so far very few publications regarding cardiac arrhythmias 
occurring during endurance sport.19–22
Herewith, we report the results of the prospective 
observational ‘Berlin Beat of Running’ study,23 demon-
strating feasibility of continuous ECG monitoring in 108 
recreational endurance athletes during a marathon race. 
The pre-defined primary aim of the study was to analyse 
the frequency of cardiac arrhythmias and especially AF in 
a cohort of recreational endurance athletes. Pre-defined 
secondary aims were as follows: (1) to assess risk factors 
associated with cardiac arrhythmias in marathon runners, 
(2) to analyse the association between laboratory findings 
and the presence of cardiac arrhythmias during the race, 
and (3) to investigate whether marathon runners with 
elevated troponin levels (after the race) have MRI-de-
tected myocardial scars suggestive of previous myocardial 
infarction.
MethODs
Study design
The Berlin Beat of Running study is a prospective, obser-
vational, investigator-initiated cohort study. The study 
design has been published in detail.23 In short, all pre-reg-
istered participants were informed by the organisers of 
the marathon about the study, and they contacted the 
study personnel if they were interested. Participants aged 
35–60 years with at least two marathon runs within the 
last 5 years and an average training of 40 km running 
per week were enrolled after giving written informed 
consent. Exclusion criteria included known cardiac 
disease or arrhythmia, prior stroke, tumour or infectious 
disease, severe liver or kidney disease, hyperthyroidism, 
pregnancy or lactation. Continuous ECG recording 
(using the CardioMem CM 4000 provided by GETEMED 
AG, Teltow, Germany) was started in 109 study partic-
ipants up to 74 hours before the 38th BMW Berlin 
Marathon and continued throughout the entire race 
and for up to 58 hours afterwards. Laboratory assessment 
including high-sensitive troponin T (hsTnT) measure-
ment with chemiluminescence immunoassays (Roche 
Diagnostics, Mannheim, Germany; cut-off 12 µg/L) was 
performed up to 74 hours before, within 30 min post-race 
and for up to 58 hours after the race. The study protocol 
is in accordance with the Helsinki declaration and was 
approved by the ethics committee of the Charité—
Universitätsmedizin Berlin (EA4/042/11). The primary 
hypothesis was cardiac arrhythmias and especially AF 
are frequently found in experienced marathon runners. 
Therefore, the primary outcome is the number of mara-
thon runners with newly diagnosed cardiac arrhythmias. 
The main secondary hypotheses were as follows: (1) there 
are predictable risk factors associated with cardiac arrhyth-
mias in marathon runners, (2) pathological laboratory 
findings are (in part) associated with cardiac arrhythmias 
and (3) marathon runners with elevated troponin levels 
do not have MRI-detected myocardial scars suggestive of 
myocardial infarction. Follow-up information on medical 
history was assessed 1 year after the marathon.
MrI analysis
A cardiac MRI after the race was offered to all study 
participants with either ST-T-segment deviation or 
hsTnT elevation. 3T MRI (Magnetom Tim Trio; Siemens 
AG) was performed using a phased array receiver coil 
during breath-holds gated to the electrocardiogram 
(Body Matrix-coil #TATS; Siemens AG). Cine images of 
3 long-axis and 14–18 short-axis views (slices of 4 mm) 
were created using a steady-state free precision tech-
nique.24 Eight minutes after intravenous administration 
of 10–12 mL Gadovist (Bayer Schering Pharma AG) at a 
concentration of 1 mmol/mL, these views were repeated 
using a short inversion recovery sequence and continu-
ously adjusting the inversion time.25
eCG analysis
ECG monitoring was performed using a two-channel 
portable ECG recorder (CardioMem CM 4000; GETEMED 
AG). The cardiologists (AT, AW and WH) who analysed 
the ECG data were blinded for demographic, clinical 
or laboratory data. The five recorded leads were placed 
as follows in order to obtain two independent bipolar 
channels: left (1) and right (2) on the first intercostal 
space, right on the sixth intercostal space parasternal 
(3) and mid-clavicular line (4), and left ninth intercostal 
space mid-clavicular line (5). As there are no published 
recommendations on interpretation of a Holter ECG 
in athletes, we followed recommendations available for 
interpreting a 12-lead ECG in athletes26 as well as recent 
EHRA guidelines on ventricular arrhythmias.18 In line 
with this, we defined an abnormal ECG as presence 
of ST-T-segment deviation under physical exercise or 
arrhythmias. Low-pass filtering was set at 0.05 Hz in order 
to detect changes in the ST-T-segment. The ST segment 
was considered abnormal in the virtually artefact-free 
two-lead ECG if horizontal or down-sloping ≥1 mm 
occurred over the 60 ms after the J-junction (80 ms if the 
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heart rate was <120 beats per minute).27 ST-segments were 
analysed in relation to the TP segment. Segments were 
analysed after recording of stable isoelectric TP segments 
in three consecutive beats. If single QRS complexes 
showed notching, slurring or fragmentation, QRS and ST 
intervals were excluded from further analysis. Episodes 
lasting more than 30 s preceded and followed by regular 
ECG recording were also considered abnormal. Drezner 
et al defined atrial arrhythmias as atrioventricular (AV) 
block grade IIb or III, AF or supraventricular tachycardia 
(SVT).26 Ventricular arrhythmias were defined as nsVT of 
at least three premature ventricular complexes (PVCs) 
and a heart rate of ≥100 beats per minute.18 26
statistical analysis
In accordance with the sample size calculation, we 
planned to include 110 participants into the study.23 For 
categorical data, absolute and relative frequencies were 
calculated using SPSS Statistics V.22. In the case of contin-
uous variables with nearly normal distribution, we used 
the arithmetic mean, SD, minimal and maximal values, 
otherwise median, quartiles, and minimal and maximal 
values. The χ2 test was used to compare proportions for 
dichotomous outcomes between independent groups or 
to test independency of two dichotomous variables within 
a population. Outcomes in an ordinal scale or continuous 
outcomes were analysed using the t-test or the Mann-
Whitney U test, depending on normality or non-normality 
of distribution. A p value of <0.05 was considered to be 
statistically significant. In multivariate analysis, potential 
impact factors identified on a p<0.05 level in univariate 
analysis were entered in a binary logistic regression model 
using backwards selection.
results
Baseline data of study participants and feasibility of ECG 
recording
Overall, 109 (99.1%) of 110 study participants took part, 
and 108 (98.2%) participants finished the 38th BMW 
Berlin Marathon 2011 in an average running time of 
249±43 min. September 25, 2011, was a sunny day in 
Berlin and temperatures reached a maximum of 22°C. 
Data quality of long-term Holter ECG was sufficient to 
ensure assessment of arrhythmias and ST-T-segment 
deviations in 107 (98.2%) athletes, although motion 
and perspiration artefacts were present in the majority 
of athletes. In one athlete’s device, a technical error 
occurred. Consistently wearing the ECG recorder on the 
upper arm using a carrier bag, no athlete reported prob-
lems in this regard. No athlete stopped wearing the ECG 
device prematurely. Baseline characteristics of these 107 
participants are depicted in table 1. The median age of 
these 107 participants was 48 years; 23.9% were women. 
The cardiovascular risk profile was low. The participants 
had run a median of five marathon races within the last 
5 years and a median of eight marathon races in total. 
Their average weekly running distance prior to the race 
was 40 km (IQR 30–50 km). In addition, athletes regularly 
went cycling (44.9%; n=48) or swimming (18.7%; n=20), 
respectively.
Cardiac arrhythmias or st-t-segment deviation during the 
marathon
During the race, mean heart rate was 156.7±9.4 beats 
per minute. Minimum and maximum median heart rate 
were 133 (IQR 120–142) and 172 (IQR 166–177) beats 
per minute, respectively. We observed nsVT in 10 (9.4%) 
athletes (figure 1), 2 (20%) of whom were women. In 
athletes with nsVTs, the median number of beats was 
3 (IQR 3–5; range 3–9), median rate was 166 beats per 
minute (IQR 149–188; range 133–224) and median dura-
tion of the recorded nsVT was 1121 ms (IQR 919–1841; 
range 901–4400). We did not observe an AV block or 
an SVT. Persistent AF was found in one male patient 
(0.9%). Filtering of the monitors allowed interpretation 
of ST–T wave changes in fashion similar to a standard 
ECG. Exercise-induced ST-T-segment deviations occurred 
in eight (7.5%) study participants during the marathon 
race (figure 2), two (25%) of whom were women. Char-
acteristics of all athletes with ST-T-segment deviation are 
displayed in the online supplementary file 1. Intensity of 
ST-T-segment deviation in terms of ST level was −0.7 mV 
(IQR −0.8 to −0.3; range −0.9 to −0.16). ECG monitoring 
was prolonged for up to 54 hours (median 28 hours) after 
the marathon race. ST-T-segment deviations were not 
found in any athlete with ST-T-segment deviation during 
the marathon. One of these eight athletes also had nsVT. 
While four (3.7%) athletes reported palpitations during 
the marathon race, one had AF, one had a single nsVT 
(lasting nine beats) and another athlete had multiple 
supraventricular premature beats (62/hour). No athlete 
reported cardiac pain or dyspnoea. An abnormal ECG 
Table 1 Baseline characteristics of the 107 participants 
of the ‘Berlin Beat of Running’ study who finished the 
marathon and who had evaluable ECG data
Age, mean, years, median (IQR) 48 (45–53)
Female gender, % (n) 24.3 (26)
Body mass index, kg/m2, median (IQR) 23.4 (21.6–24.7)
Hypertension, % (n) 8.4 (9)
Diabetes mellitus, % (n) 0 (0)
Heart failure, % (n) 0 (0)
Coronary artery disease, % (n) 0 (0)
Hyperlipidaemia, % (n) 2.8 (3)
Current smoking, % (n) 6.5 (7)
Medication at enrolment
  Antiplatelet, % (n) 0.9 (1)
  Oral anticoagulant, % (n) 0
  Beta-blocker, % (n) 1.9 (2)
  Statin, % (n) 1.9 (2)
  Antihypertensive, % (n) 6.5 (7)
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according to pre-defined criteria was found in 16.8% 
(n=18) of all participants. In univariate analysis, advanced 
age (p=0.004) and a longer marathon finishing time 
(p=0.009) were associated with abnormal ECG findings, 
while sex, cardiovascular risk profile, haematocrit post-
race and the number of previous marathons were not. 
In multivariate analysis, advanced age remained signifi-
cant (OR 1.11 per year, 95% CI 1.01 to 1.23) (table 2). In 
addition, athletes with an abnormal ECG had a higher 
frequency of PVCs (median 3.0 (IQR 1.0 to 12.3) vs 23.5 
(IQR 10.0 to 44.0), p<0.001) during the marathon race.
Cardiac biomarkers and eCG changes during the marathon
At baseline, hsTnT was normal in all marathon runners 
(<50 ng/L). Within minutes after the race was finished, 
hsTnT was elevated above 50 ng/L in 18 (16.8%) partic-
ipants and median hsTnT was 3 ng/L (IQR 2–4; range 
1–22). Median hsTnT values in 18 athletes with elevated 
hsTnT was 68.5 ng/L (IQR 62.8–85.5; range 50–216). 
Characteristics of all athletes with elevated hsTnT 
are displayed in the online supplementary file 1. In 
all athletes, median creatine kinase (CK) and CK-MB 
were 130 U/L (IQR 103–176) and 20 U/L (IQR 17–24) 
pre-marathon, respectively. Post-marathon CK was 336 
(IQR 252–417) U/L and CK-MB was 35 (IQR 29–41) U/L.
Comparing athletes with an elevated hsTnT post–mara-
thon with those without, we found no difference in age, 
sex, cardiovascular risk factors, training level or post-mar-
athon CK-MB values (table 3). In runners with elevated 
hsTnT, we found more frequent ST-T-segment deviations 
(p<0.0001) but no association with cardiac arrhythmias. 
In addition, elevated hsTnT was found in individuals with 
a longer marathon finishing time (p=0.040). Athletes 
with elevated hsTnT had a lower haematocrit compared 
with athletes without hsTnT elevation (p=0.003). In 
Figure 1 Non-sustained ventricular tachycardia in a well-trained 48-year-old male endurance runner without cardiovascular 
risk factors despite smoking.
Figure 2 ECG at rest (A) and exercise-induced ST-segment deviations (B) in a 60-year-old male endurance runner without 
cardiovascular risk.
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multivariate analysis, ST-T-segment deviation (OR 9.9, 
95% CI 1.9 to 51.5) as well as haematocrit (OR 0.76%, 
95% CI 0.62 to 0.92) remained statistically significant. 
Within 48 hours post-marathon, hsTnT was within 
normal range in 106 (99.1%) athletes; one athlete with 
no substantial ECG alterations during the marathon 
showed a persisting hsTnT elevation but normal 12-lead 
ECG post-marathon. Follow-up information was available 
for all 8 athletes with ST-T-segment deviation and for 8 
out of 10 patients with nsVT during the race. None of 
the athletes reported a cardiovascular event within 1 year 
after the race.
Cardiac MrI in athletes with st-t-segment deviation or 
elevated hstnt
Cardiac MRI was offered to all study participants with 
ST-T-segment deviation or hsTnT elevation. Five out of 
eight athletes with ST-T-segment deviation and hsTnT 
elevation as well as in 5 out of 18 athletes with hsTnT 
elevation but without ST-T-segment deviation under-
went MRI within 10–42 days after the marathon race. 
Age, sex and cardiovascular risk factors did not differ 
in the 10 athletes undergoing cardiac MRI and the 14 
athletes who did not undergo cardiac MRI. Cardiac MRI 
revealed no pathological findings for cardiac function, 
and there was no late gadolinium enhancement indi-
cating myocardial fibrosis. Additional cardiac work-up 
was strongly recommended in all patients with patholog-
ical ECG findings.
DIsCussIOn
This is so far the largest study demonstrating feasibility of 
ECG recording during a marathon race, which may help 
counselling a subset of endurance athletes regarding 
exercise-associated complications. One main finding of 
the Berlin Beat of Running study is the unexpectedly 
high rate of abnormal ECG findings in 17% of recre-
ational endurance athletes. Moreover, this is the first 
study reporting an association of transient ST-T-segment 
abnormalities during a marathon with elevated hsTnT 
levels after finishing the race. However, we cannot be sure 
that the observed ST-T-segment deviations are definitively 
based on silent ischaemia.
So far, there is limited data on ECG abnormalities during 
vigorous exercise.28 Franco et al reported ‘no arrhythmias’ 
in 19 male athletes during a marathon,21 while Aagaard et 
al found ‘no ventricular arrhythmias’ but AF in 2 (4%) 
of 49 male endurance runners during a 30-km race.22 
Luurila et al reported the presence of ventricular prema-
ture complexes in 33 (89%) of 37 recreational athletes 
during a ski marathon as well as ST-T-segment deviations 
in three (8%) of these middle-aged men.20 Most recently, 
Grabs et al used a one-lead wireless ECG and reported 
premature atrial contractions but no arrhythmias in 20 
male runners during a marathon race.19 In our prospec-
tive study, 10 (9.4%) out of 107 recreational endurance 
athletes had a non-sustained ventricular arrhythmia 
during the marathon and one (0.9%) athlete had AF. 
In addition, ST-T-segment deviations (figure 2) were 
Table 2 Cardiovascular risk profile and training status of recreational athletes with or without abnormal ECG findings, 
respectively
Normal
ECG Abnormal ECG
Univariate 
analysis Multivariate analysis
n=89 n=18 p Value* OR (95% CI)
Age, years, median (IQR) 48 (44–50) 54 (48–59) 0.004 1.11 (1.01 to 1.23)
Female gender, % (n) 24.7 (22) 22.2 (4) 0.822
Physical activity
  Marathon runs ≤5 years, median (IQR) 5 (4–10) 6 (4–7) 0.923
  Marathon runs total, n, median (IQR) 9 (5–18) 7 (6–14) 0.573
  Current running, km/week, median (IQR) 65 (50–80) 58 (50–70) 0.151
  Regular running, km/week, median (IQR) 40 (30–50) 40 (30–50) 0.409
  Present marathon time, min, median (IQR) 238 (215–268) 275 (229–326) 0.009 1.44 (0.98 to 2.12)
  Haematocrit post-race, %, median (IQR) 0.44 (0.41–0.45) 0.43 (0.41–0.45) 0.711
Body mass index, kg/m2, mean±SD 23.2±2.2 23.6±1.9 0.449
Comorbidities
  Hypertension, % (n) 6.7 (6) 16.7 (3) 0.166
  Hyperlipidaemia, % (n) 2.2 (2) 2.8 (3) 0.438
  Current smoking, % (n) 5.6 (5) 11.1 (2) 0.390
ST-segment deviation, atrioventricular or ventricular arrhythmias (atrioventricular block grade IIb or III, triplets, non-sustained ventricular 
tachycardia, supraventricular tachycardia) or atrial fibrillation were regarded as abnormal findings. Values are expressed in % (n), mean±SD or 
median (IQR) as appropriate. Multivariate analysis was calculated in a binary logistic regression model using backwards selection.
*p Value calculated by χ2 test or Mann-Whitney U test, as appropriate.
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detected in eight (7.5%) athletes. Advanced age was asso-
ciated with abnormal ECG findings (table 2). According 
to the haematocrit, low hydration—potentially impacting 
on cardiac preload—was not linked to abnormal ECG 
findings. However, analysing athletes with ST-T-segment 
deviations, AF or ventricular arrhythmias, the underlying 
mechanisms of these pathological conditions may differ 
and the results of the multivariate analysis do not apply to 
a single condition.
Despite the fact that increased levels of physical activity 
were associated with a lower relative risk of myocardial 
infarction, 4% of patients with myocardial infarction 
report having performed strenuous exercise within 
hours before the cardiovascular event.3 By using different 
cut-offs, transient elevations in the level of troponin T or 
troponin I have previously been reported in 18%–69% of 
marathon runners.10–12 29 In the Berlin Beat of Running 
cohort, hsTnT was elevated in 18 (17%) out of 107 athletes 
but normalised within 48 hours in 17 (94%) athletes. 
Interestingly, elevation of hsTnT was not related to age, 
sex, training status, the cardiovascular risk profile or the 
presence of cardiac arrhythmias during the race, but 
was related to exercise-induced ST-T-segment deviation 
(p<0.0001) and inversely correlated with the haematocrit 
(measured immediately after the race).
Cardiac MRI is now the gold standard for detecting 
myocardial damage30 and myocardial oedema as well as 
decreased ventricular function after a marathon race.31 32 
We were not able to demonstrate late gadolinium enhance-
ment as an indicator of permanent myocardial fibrosis 
Table 3 Troponin T elevation post-marathon in the 107 athletes who finished the marathon race and who had evaluable ECG 
data
Troponin T
<50 ng/L n=89
Troponin T
≥50 ng/L n=18
Univariate analysis p 
Value*
Multivariate 
analysis OR (95% CI)
Age, years, median 
(IQR)
48 (45–52) 49 (45–53) 0.605
Female gender, % (n) 21.3 (19) 38.9 (7) 0.114
Body mass index, kg/
m2, mean±SD
23 (22–25) 23 (22–25) 0.723
Present marathon time, 
min, median (IQR)
236 (217–269) 268 (237–309) 0.040 1.25 (0.83 to 1.87)
Marathon runs ≤5 years, 
n, median (IQR)
6 (4–10) 5 (3–8) 0.327
Marathon runs total, n, 
median (IQR)
9 (6–18) 7 (5–12) 0.147
Regular weekly running, 
km, median (IQR)
40 (30–50) 40 (30–50) 0.791
Coexisting 
hypertension, % (n)
9.0 (8) 5.6 (1) 0.632
Hyperlipidaemia, % (n) 3.4 (3) 0 (0) 0.429
ST-T-segment deviation, 
% (n)
3.4 (3) 27.8 (5) <0.0001 9.9 (1.90 to 51.5)
Arrhythmias, % (n) 11.2 (10) 5.6 (1) 0.469
Troponin pre-race, µg/L, 
median (IQR)
0.012 (0.012–0.012) 0.012 (0.012–0.012) 0.131
Creatinine pre-race, mg/
dL, median (IQR)
0.86 (0.81–0.96) 0.85 (0.77–0.97) 0.761
Creatinine post-race, 
mg/dL, median (IQR)
1.27 (1.11–1.46) 1.34 (1.17–1.48) 0.424
CK post-race, U/L, 
median (IQR)
333 (250–412) 350 (291–611) 0.263
CK-MB post-race, U/L, 
median (IQR)
35 (28 to 41) 33 (29 to 52) 0.609
Haematocrit post-race, 
%, median (IQR)
44 (42–46) 41 (39–44) 0.003 0.76 (0.62 to 0.92)
Values are expressed in percent (n), mean±SD or median (IQR) as appropriate. Multivariate analysis was calculated in a binary logistic 
regression model using backwards selection.
 *p Value calculated by χ2 test or Mann-Whitney U test, as appropriate.
CK, creatine kinase.
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in 10 experienced recreational athletes with ST-T-seg-
ment deviation or detected cardiac arrhythmia. This is in 
line with a previous study reporting no late gadolinium 
enhancement in 20 recreational athletes within 48 hours 
after a marathon race.31 Interestingly, a transient cardiac 
oedema was reported in 17 (85%) out of 20 marathon 
runners,31 but no correlation was reported between 
biomarkers and cardiac oedema. We are, however, 
unable to exclude a transient cardiac oedema in mara-
thon runners because cardiac MRI was performed within 
10–42 days after the marathon race.
Taken together, vigorous exercise can go along with 
transient troponin elevation, ST-T-segment alterations 
or nsVT in a fit and active population. However, athletes 
with ST-T-segment deviation or nsVT during the race did 
not report a cardiovascular event within 1 year afterwards. 
Thus, these findings are likely to be benign, but it was 
still recommended to rule out structural heart disease 
or obstructive coronary artery disease in these athletes. 
Our results strengthen the assumption that hsTnT eleva-
tion originates from the heart and not primarily from 
non-cardiac sources.8 However, we are unable to draw 
final conclusions. Whether borderline cardiac damage 
by repetitive strenuous exercise could lead to perma-
nent (potentially arrhythmogenic) cardiac remodelling is 
under debate.6 33
Focusing primarily on the feasibility of portable ECG 
monitoring and detection of ECG changes during the 
race, major limitations of the observational ‘Berlin Beat 
of Running’ study are the missing (serial) echocardiog-
raphy or cardiac stress MRI, thus limiting the clinical 
significance of the observed ST-T-segment changes and 
elevated hsTnT levels. Furthermore, a normal cardiac 
MRI within days after the race does not completely rule 
out (transient) exercise-induced cardiac damage.34 Since 
only one-fourth of all athletes were women and because 
of a potential selection bias during enrolment, the gener-
alisability of our results is limited. Moreover, due to the 
limited number of endpoints observed, we believe that 
the results of the multivariate analysis should be inter-
preted with caution. Combining nsVT and ST-T-segment 
deviations for statistical analysis may have introduced 
an information bias. Unfortunately, it was impossible to 
assess the mean duration of ST-T-segment deviation in 
more detail, as ST-T-segment changes were present inter-
mittently. Finally, exercise capacity testing would have 
allowed more accurate evaluation of training status.
COnClusIOn
ECG recording during a marathon race is feasible, which 
may be helpful in the diagnostic work-up of selected 
athletes. Cardiac arrhythmias or exercise-induced 
ST-T-segment deviations appear in a relevant subset of 
experienced recreational athletes during a marathon 
race and predominantly in older athletes. Marathon-in-
duced ST-T-segment deviations were associated with 
elevated hsTnT values immediately after the race. Cardiac 
MRI detected no myocardial fibrosis by late gadolinium 
enhancement in a subset of these athletes.
Author affiliations
1Department of Neurology, Charité—Universitätsmedizin Berlin, Berlin, Germany
2Center for Stroke Research Berlin, Charité—Universitätsmedizin Berlin, Berlin, 
Berlin, Germany
3Working Group on Cardiovascular Magnetic Resonance, Experimental and Clinical 
Research Center, Berlin, Germany
4Department of Cardiology and Nephrology, HELIOS Klinikum Berlin Buch, Berlin, 
Germany
5Department of Cardiology, Campus Virchow Klinikum, Charité—Universitätsmedizin 
Berlin, Berlin, Germany
6SMS Medical Institute Berlin GmbH, Berlin, Germany
7SCC EVENTS GmbH, Berlin, Germany
8Berlin Academy of Sports Medicine, Berlin, Germany
9Institute of Clinical Epidemiology and Biometry, University of Würzburg, Würzburg, 
Germany
10Clinical Trial Center Würzburg, University Hospital Würzburg, Würzburg, Germany
11German Center for Neurodegenerative Diseases (DZNE), Partner Site Berlin, Berlin, 
Germany
12German Center for Cardiovascular Diseases (DZHK), Partner Site Berlin, Berlin, 
Germany
13Berlin Institute of Health, Berlin, Germany
14Department of Neurology, Jüdisches Krankenhaus Berlin, Berlin, Germany
Acknowledgements The results of this study are presented clearly, honestly and 
without fabrication, falsification or inappropriate data manipulation, and we state 
that results of this study do not constitute endorsement by ACSM. We appreciate 
the work of the organising SCC EVENTS GmbH who supported the Berlin Beat of 
Running study in an outstanding manner. We would like to thank all members of 
the Berlin Beat of Running study team23 and all athletes for their participation. 
In addition, we thank Catherine Aubel (CSB) and Julia Herde (CSB) for critically 
reviewing the manuscript.
Contributors JH has made substantial contributions to acquisition, analysis 
and interpretation of data and drafted the manuscript. AT and AW have made 
substantial contributions to data analysis and interpretation of data. CK has made 
substantial contributions to design and acquisition of data. MK, LB, JL, JBF, WH 
and ME revised the manuscript critically for important intellectual content. PUH 
has made substantial contributions to analysis and interpretation of data and 
revised the manuscript critically for important intellectual content. GJJ has made 
substantial contributions to conception and design and revised the manuscript 
critically for important intellectual content. KGH has made substantial contributions 
to conception and design, analysis and interpretation of data and drafted the 
manuscript.
Funding The investigator-initiated “Berlin Beat of Running” study was supported 
by the SCC EVENTS GmbH, Berlin. Bayer Healthcare (Leverkusen, Germany) and 
Sanofi-Aventis Deutschland GmbH (Berlin, Germany) supported the study with an 
unrestricted grant. The GETEMED AG (Teltow, Germany) provided the ECG-recorders 
and comprehensive technical support. KGH, JH, CK, JBF, ME and GJJ received 
funding from the Federal Ministry of Education and Research via the grant 
Center for Stroke Research Berlin (01 EO 0801). ME received support from the 
Volkswagen-Stiftung, Deutsche Forschungsgemeinschaft and the EU.
Competing interests JH reports no conflict of interest. AT reports lecture fees 
from the Circle Institute. MK received consulting, lecture and advisory board fees 
from ALK, Berlin Chemie, Novartis, Mundipharma and Teva. LB reports research 
support from the German Ministry of Research and Education. JBF reports the 
following board memberships, consultancies and/or payments for lectures including 
service on speaker’s bureaus: Boehringer Ingelheim, Lundbeck, BioClinica and 
Parexel. PUH reports research grants from the German Ministry of Research and 
Education, EU, Charité, Berlin Chamber of Physicians, German Parkinson Society, 
University Hospital Würzburg, Robert Koch Institute, Charité—Universitätsmedizin 
Berlin (within MonDAFIS; MonDAFIS is supported by an unrestricted research 
grant to the Charité from Bayer Healthcare), University Göttingen (within FINDAF 
randomized; FINDAF randomized is supported by an unrestricted research grant 
to the University Göttingen from Boehringer Ingelheim) and University Hospital 
Heidelberg (within RASUNOAprime; RASUNOAprime is supported by an unrestricted 
research grant to the University Hospital Heidelberg from Bayer Healthcare, BMS 
and Boehringer Ingelheim), outside submitted work. GJJ has received funding from 
group.bmj.com on August 9, 2017 - Published by http://bmjopen.bmj.com/Downloaded from 
8 Herm J, et al. BMJ Open 2017;7:e015798. doi:10.1136/bmjopen-2016-015798
Open Access 
the German Ministry for Education and Research. He has served on the Critical 
Event committees of the SourceXT registry and the ProTAVIC study (Edwards 
Lifesciences, USA). He serves as a consultant for Cipio Partners (Munich, Germany 
and Elron, Tel Aviv, Israel). He has received speakers’ honoraria from Genzyme and 
Pfizer (20102013). ME and KGH report lecture fees and study grants from Sanofi-
Aventis and Bayer Healthcare.
Patient consent Obtained.
ethics approval Ethics Commitee of the Charité—Universitaetsmedizin Berlin.
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement There are no additional data available for this study.
Open Access This is an Open Access article distributed in accordance with the 
Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which 
permits others to distribute, remix, adapt, build upon this work non-commercially, 
and license their derivative works on different terms, provided the original work is 
properly cited and the use is non-commercial. See: http:// creativecommons. org/ 
licenses/ by- nc/ 4. 0/
© Article author(s) (or their employer(s) unless otherwise stated in the text of the 
article) 2017. All rights reserved. No commercial use is permitted unless otherwise 
expressly granted.
reFerenCes
 1. Chakravarty EF, Hubert HB, Lingala VB, et al. Reduced disability and 
mortality among aging runners: a 21-year longitudinal study. Arch 
Intern Med 2008;168:1638–46.
 2. Soares-Miranda L, Siscovick DS, Psaty BM, et al. Physical activity 
and risk of coronary heart disease and stroke in older adults: the 
Cardiovascular Health Study. Circulation 2016;133:147–55.
 3. Mittleman MA, Maclure M, Tofler GH, et al. Triggering of acute 
myocardial infarction by heavy physical exertion. Protection against 
triggering by regular exertion. Determinants of Myocardial Infarction 
Onset Study Investigators. N Engl J Med 1993;329:1677–83.
 4. Winzer BM, Whiteman DC, Reeves MM, et al. Physical activity and 
cancer prevention: a systematic review of clinical trials. Cancer 
Causes Control 2011;22:811–26.
 5. Carek PJ, Laibstain SE, Carek SM. Exercise for the treatment of 
depression and anxiety. Int J Psychiatry Med 2011;41:15–28.
 6. La Gerche A, Heidbuchel H. Can intensive exercise harm the 
heart? You can get too much of a good thing. Circulation 
2014;130:992–1002.
 7. Kim JH, Malhotra R, Chiampas G, et al. Cardiac arrest during long-
distance running races. N Engl J Med 2012;366:130–40.
 8. Albano AJ, Thompson PD, Kapur NK. Acute coronary thrombosis in 
Boston marathon runners. N Engl J Med 2012;366:184–5.
 9. Gerardin B, Collet JP, Mustafic H, et al. Registry on acute 
cardiovascular events during endurance running races: the 
prospective RACE Paris registry. Eur Heart J 2016;37:2531–41.
 10. Eijsvogels TM, Hoogerwerf MD, Maessen MF, et al. Predictors 
of cardiac troponin release after a marathon. J Sci Med Sport 
2015;18:88–92.
 11. Mehta R, Gaze D, Mohan S, et al. Post-exercise cardiac troponin 
release is related to exercise training history. Int J Sports Med 
2012;33:333–7.
 12. Fortescue EB, Shin AY, Greenes DS, et al. Cardiac troponin 
increases among runners in the Boston Marathon. Ann Emerg Med 
2007;49:137–43.
 13. O'Keefe JH, Patil HR, Lavie CJ, et al. Potential adverse 
cardiovascular effects from excessive endurance exercise. Mayo Clin 
Proc 2012;87:587–95.
 14. Heidbüchel H, Hoogsteen J, Fagard R, et al. High prevalence of 
right ventricular involvement in endurance athletes with ventricular 
arrhythmias. Role of an electrophysiologic study in risk stratification. 
Eur Heart J 2003;24:1473–80.
 15. Harper RW, Mottram PM. Exercise-induced right ventricular 
dysplasia/cardiomyopathy—an emerging condition distinct from 
arrhythmogenic right ventricular dysplasia/cardiomyopathy. Heart 
Lung Circ 2009;18:233–5.
 16. Abdulla J, Nielsen JR. Is the risk of atrial fibrillation higher in athletes 
than in the general population? A systematic review and meta-
analysis. Europace 2009;11:1156–9.
 17. Andersen K, Farahmand B, Ahlbom A, et al. Risk of arrhythmias in 52 
755 long-distance cross-country skiers: a cohort study. Eur Heart J 
2013;34:3624–31.
 18. Pedersen CT, Kay GN, Kalman J, et al. EHRA/HRS/APHRS expert 
consensus on ventricular arrhythmias. Europace 2014;16:1257–83.
 19. Grabs V, Peres T, Zelger O, et al. Decreased prevalence of cardiac 
arrhythmias during and after vigorous and prolonged exercise in 
healthy male marathon runners. Am Heart J 2015;170:149–55.
 20. Luurila OJ, Karjalainen J, Viitasalo M, et al. Arrhythmias and ST 
segment deviation during prolonged exhaustive exercise (ski 
marathon) in healthy middle-aged men. Eur Heart J 1994;15:507–13.
 21. Franco V, Callaway C, Salcido D, et al. Characterization of 
electrocardiogram changes throughout a marathon. Eur J Appl 
Physiol 2014;114:1725–35.
 22. Aagaard P, Sahlén A, Bergfeldt L, et al. Heart rate and its variability 
in response to running-associations with troponin. Med Sci Sports 
Exerc 2014;46:1624–30.
 23. Haeusler KG, Herm J, Kunze C, et al. Rate of cardiac arrhythmias 
and silent brain lesions in experienced marathon runners: rationale, 
design and baseline data of the Berlin Beat of Running study. BMC 
Cardiovasc Disord 2012;12:69.
 24. Carr JC, Simonetti O, Bundy J, et al. Cine MR angiography of the 
heart with segmented true fast imaging with steady-state precession. 
Radiology 2001;219:828–34.
 25. Simonetti OP, Kim RJ, Fieno DS, et al. An improved MR imaging 
technique for the visualization of myocardial infarction. Radiology 
2001;218:215–23.
 26. Drezner JA, Ackerman MJ, Anderson J, et al. Electrocardiographic 
interpretation in athletes: the ‘Seattle criteria’. Br J Sports Med 
2013;47:122–4.
 27. Gramatikov B, Iyer V. Intra-QRS spectral changes accompany 
ST segment changes during episodes of myocardial ischemia. J 
Electrocardiol 2015;48:115–22.
 28. Spethmann S, Prescher S, Dreger H, et al. Electrocardiographic 
monitoring during marathon running: a proof of feasibility for a new 
telemedical approach. Eur J Prev Cardiol 2014;21:32–7.
 29. George K, Whyte G, Stephenson C, et al. Postexercise left ventricular 
function and cTnT in recreational marathon runners. Med Sci Sports 
Exerc 2004;36:1709–15.
 30. Utomi V, Oxborough D, Whyte GP, et al. Systematic review and meta-
analysis of training mode, imaging modality and body size influences 
on the morphology and function of the male athlete’s heart. Heart 
2013;99:1727–33.
 31. Gaudreault V, Tizon-Marcos H, Poirier P, et al. Transient myocardial 
tissue and function changes during a marathon in less fit marathon 
runners. Can J Cardiol 2013;29:1269–76.
 32. Karlstedt E, Chelvanathan A, Da Silva M, et al. The impact of 
repeated marathon running on cardiovascular function in the aging 
population. J Cardiovasc Magn Reson 2012;14:58.
 33. Wilson M, O’Hanlon R, Prasad S, et al. Diverse patterns of 
myocardial fibrosis in lifelong, veteran endurance athletes. J Appl 
Physiol 2011;110:1622–6.
 34. La Gerche A, Burns AT, Mooney DJ, et al. Exercise-induced right 
ventricular dysfunction and structural remodelling in endurance 
athletes. Eur Heart J 2012;33:998–1006.
group.bmj.com on August 9, 2017 - Published by http://bmjopen.bmj.com/Downloaded from 
observational Berlin Beat of Running study
marathon race: results of the prospective 
recreational endurance athletes during a
deviations and cardiac arrhythmias in 
Frequency of exercise-induced ST-T-segment
Jungehulsing and Karl Georg Haeusler
Heuschmann, Wilhelm Haverkamp, Matthias Endres, Gerhard Jan
Matthias Krüll, Lars Brechtel, Jürgen Lock, Jochen B Fiebach, Peter U 
Juliane Herm, Agnieszka Töpper, Alexander Wutzler, Claudia Kunze,
doi: 10.1136/bmjopen-2016-015798
2017 7: BMJ Open 
 http://bmjopen.bmj.com/content/7/8/e015798
Updated information and services can be found at: 
These include:
References
 #BIBLhttp://bmjopen.bmj.com/content/7/8/e015798
This article cites 34 articles, 5 of which you can access for free at: 
Open Access
 http://creativecommons.org/licenses/by-nc/4.0/non-commercial. See: 
provided the original work is properly cited and the use is
non-commercially, and license their derivative works on different terms, 
permits others to distribute, remix, adapt, build upon this work
Commons Attribution Non Commercial (CC BY-NC 4.0) license, which 
This is an Open Access article distributed in accordance with the Creative
service
Email alerting
box at the top right corner of the online article. 
Receive free email alerts when new articles cite this article. Sign up in the
Collections
Topic Articles on similar topics can be found in the following collections 
 (216)Sports and exercise medicine
 (772)Cardiovascular medicine
Notes
http://group.bmj.com/group/rights-licensing/permissions
To request permissions go to:
http://journals.bmj.com/cgi/reprintform
To order reprints go to:
http://group.bmj.com/subscribe/
To subscribe to BMJ go to:
group.bmj.com on August 9, 2017 - Published by http://bmjopen.bmj.com/Downloaded from 
